Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Scion Neurostim

Request full access

Committed to developing a home use, non-invasive treatment for Parkinson’s disease

Durham, United StatesFounded 2007Health Tech & Medtech

About Scion Neurostim

Scion NeuroStim, Inc. operates as a medical device company, directing its efforts toward developing non-invasive neuromodulation technologies for patients with central nervous system diseases and disorders. The company, initially formed in 2007 and headquartered in Durham, North Carolina, is a privately held entity. A significant milestone was achieved in October 2023, when the company secured approximately $10 million in a Series C equity funding round involving 13 investors, adding to previous funding rounds.

The company’s core business revolves around the manufacturing and development of neurostimulator devices designed to be easy to use. Its product pipeline is built on stimulating innate protective pathways to manage conditions like pain. One of its key products is the TNM™ Device, which utilizes thermal vestibular stimulation through earpieces to treat headache and migraine. This device, which looks like a pair of headphones, delivers controlled thermal waveforms to modulate neural areas, including the brainstem. In 2018, the FDA granted marketing authorization for the TNM™ device for the prophylactic treatment of episodic migraine in patients aged 12 and older. The technology is based on the principle of caloric vestibular stimulation.

Scion NeuroStim is also actively engaged in clinical trials to expand the application of its technology. One area of focus is Parkinson's disease, where studies have explored the device's potential to improve both motor and non-motor symptoms as an adjunctive therapy to standard care. A study on Parkinson's disease dementia (PDD) aims to evaluate the safety and feasibility of the device for improving cognitive function. The company holds a substantial intellectual property portfolio with numerous patents granted and pending in the U.S. and internationally. While some devices are authorized for specific uses, others, like the TNM™ Device 4.0, are designated as Breakthrough Devices by the FDA and are currently limited to investigational use in clinical trials. Key figures associated with the company include directors Lanty Smith and Steven Bischoff, Chief Medical Officer Dr. Lesco Rogers, and CTO/COO Robert Black.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
53.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Neurology, Alzheimers Disease, Chronic Disease, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Aug 2023 $10M $40M Undisclosed ↗
GRANTOther financing Jan 2010 $40K — NC IDEA ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Scion Neurostim website traffic

Latest recorded traffic for Scion Neurostim is 180 monthly website visits, down 18.2% over the last three months. Scion Neurostim's team grew 0% over the past year.

Latest monthly visits180 3-month web change-18.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
NIBS NeuroScience TechnologiesImaging algorithm system for monitoring brain disorders Tzur Moshe, Israel Operational 1 — —
EncefaDevelops biologics that specifically modulate a key age-related target, to fight neurodegenerative, auto-immune, and more broadly age-related diseases Paris, France Operational
Noctrix HealthEarly-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness Pleasanton, United States Acquired
Saluda MedicalDedicated to improving the lives of people by providing personalized, responsive, and efficient neuromodulation therapy (spinal cord stimulation ) Sydney, Australia Operational
PositrigoDeveloping a brain positron emission tomography system to offer functional brain imaging to everyone at a more accessible price. Zurich, Switzerland Operational
RetiSpecRetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye Canada Operational
AltoidaUses augmented reality to diagnose Alzheimer's disease Washington DC, United States Operational
BrainswayBrainsway is the developer of Deep Transcranial Magnetic Stimulation (TMS) Therapy, a patented, noninvasive, FDA-cleared solution for treating depressive episodes in adult patients suffering from major depressive disorder who have failed to achieve s Burlington, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Scion Neurostim in the Durham ecosystem

Live from Dealroom

The Scion Neurostim office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • NC IDEA
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Durham HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Scion Neurostim on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Scion Neurostim’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.